Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001179110-18-008556
Filing Date
2018-06-15
Accepted
2018-06-15 07:24:08
Documents
2
Period of Report
2018-06-13

Document Format Files

Seq Description Document Type Size
1 FORM 4 - edgar.html 4  
1 FORM 4 - edgar.xml 4 3886
2 shoos_poa2017.htm EX-24 4897
  Complete submission text file 0001179110-18-008556.txt   10421
Mailing Address 53 FRONTAGE ROAD SUITE 220 HAMPTON NJ 08827
Business Address 53 FRONTAGE ROAD SUITE 220 HAMPTON NJ 08827 908-200-7500
Celldex Therapeutics, Inc. (Issuer) CIK: 0000744218 (see all company filings)

EIN.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 8101 GLENBROOK ROAD BETHESDA MD 20814
Business Address
Shoos Karen L. (Reporting) CIK: 0001255681 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-15006 | Film No.: 18900748